710
Participants
Start Date
March 10, 2008
Primary Completion Date
April 13, 2009
Study Completion Date
April 13, 2009
Casopitant
Experimental NK-1 receptor antagonist
Dexamethasone
Standard antiemetics
Placebo
Placebo to match IV casopitant
Ondansetron
Standard antiemetics
GSK Investigational Site, Budapest
GSK Investigational Site, Budapest
GSK Investigational Site, Ottignies
GSK Investigational Site, Sofia
GSK Investigational Site, Bonheiden
GSK Investigational Site, Gyula
GSK Investigational Site, Veszprém
GSK Investigational Site, Assebroek
GSK Investigational Site, Ghent
GSK Investigational Site, Varna
GSK Investigational Site, Shumen
GSK Investigational Site, The Bronx
GSK Investigational Site, Genoa
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Lübeck
GSK Investigational Site, Pinneberg
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Sumter
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Hilton Head Island
GSK Investigational Site, Hanover
GSK Investigational Site, Tampa
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Kassel
GSK Investigational Site, Padua
GSK Investigational Site, Braunschweig
GSK Investigational Site, Magdeburg
GSK Investigational Site, Essen
GSK Investigational Site, Recklinghausen
GSK Investigational Site, Florence
GSK Investigational Site, Würselen
GSK Investigational Site, Great Falls
GSK Investigational Site, Aschaffenburg
GSK Investigational Site, Jefferson City
GSK Investigational Site, Bad Soden
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Alexandria
GSK Investigational Site, Hot Springs
GSK Investigational Site, Duncanville
GSK Investigational Site, Corpus Christi
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Napoli
GSK Investigational Site, Munich
GSK Investigational Site, Benevento
GSK Investigational Site, Avellino
GSK Investigational Site, Ogden
GSK Investigational Site, Rionero in Vulture (PZ)
GSK Investigational Site, Potenza
GSK Investigational Site, Augsburg
GSK Investigational Site, Ulm
GSK Investigational Site, Reggio Calabria
GSK Investigational Site, Riverside
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Corona
GSK Investigational Site, Hof
GSK Investigational Site, Catania
GSK Investigational Site, Würzburg
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Kazan'
GSK Investigational Site, Samara
GSK Investigational Site, Baltimore
GSK Investigational Site, Boston
GSK Investigational Site, Worcester
GSK Investigational Site, Corpus Christi
GSK Investigational Site, Burlington
GSK Investigational Site, Sault Ste. Marie
GSK Investigational Site, Thunder Bay
GSK Investigational Site, Toronto
GSK Investigational Site, Charlottetown
GSK Investigational Site, Greenfield Park
GSK Investigational Site, Laval
GSK Investigational Site, Montreal
GSK Investigational Site, Rimouski
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Brno
GSK Investigational Site, Brno
GSK Investigational Site, Chomutov
GSK Investigational Site, Havlíčkův Brod
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Semily
GSK Investigational Site, Jena
GSK Investigational Site, Sassari
GSK Investigational Site, Terni
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow Region
GSK Investigational Site, Banská Bystrica
GSK Investigational Site, Bratislava
GSK Investigational Site, Košice
GSK Investigational Site, Poprad
GSK Investigational Site, Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Songpa-gu, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY